- Home
- SMTI vs SLP Comparison
SMTI vs SLP Comparison
Compare SMTI & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- SLP
- Stock Information
- Founded
- SMTI 1982
- SLP 1996
- Country
- SMTI United States
- SLP United States
- Employees
- SMTI N/A
- SLP N/A
- Industry
- SMTI Medical/Dental Instruments
- SLP EDP Services
- Sector
- SMTI Health Care
- SLP Technology
- Exchange
- SMTI Nasdaq
- SLP Nasdaq
- Market Cap
- SMTI 243.3M
- SLP 261.0M
- IPO Year
- SMTI N/A
- SLP 1997
- Fundamental
- Price
- SMTI $29.68
- SLP $14.24
- Analyst Decision
- SMTI Strong Buy
- SLP Buy
- Analyst Count
- SMTI 2
- SLP 7
- Target Price
- SMTI $49.50
- SLP $29.50
- AVG Volume (30 Days)
- SMTI 44.0K
- SLP 559.2K
- Earning Date
- SMTI 08-13-2025
- SLP 07-14-2025
- Dividend Yield
- SMTI N/A
- SLP N/A
- EPS Growth
- SMTI N/A
- SLP N/A
- EPS
- SMTI N/A
- SLP N/A
- Revenue
- SMTI $97,241,894.00
- SLP $80,383,000.00
- Revenue This Year
- SMTI $22.70
- SLP $15.28
- Revenue Next Year
- SMTI $13.56
- SLP $0.79
- P/E Ratio
- SMTI N/A
- SLP N/A
- Revenue Growth
- SMTI 34.29
- SLP 20.01
- 52 Week Low
- SMTI $23.53
- SLP $12.39
- 52 Week High
- SMTI $39.08
- SLP $37.72
- Technical
- Relative Strength Index (RSI)
- SMTI 60.76
- SLP 45.17
- Support Level
- SMTI $23.53
- SLP $13.90
- Resistance Level
- SMTI $32.00
- SLP $14.59
- Average True Range (ATR)
- SMTI 1.41
- SLP 0.52
- MACD
- SMTI 0.78
- SLP 0.45
- Stochastic Oscillator
- SMTI 72.61
- SLP 83.17
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.